Caveolin-1 mediates tissue plasminogen activator-induced MMP-9 up-regulation in cultured brain microvascular

Xinchun Jin1, Yanyun Sun, Ji Xu

  • 1Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and Institute of Neuroscience, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.

Journal of Neurochemistry
|February 17, 2015
PubMed

Insights

Tissue plasminogen activator (tPA) increases matrix metalloproteinase-9 (MMP-9) via caveolin-1 in brain endothelial cells. This finding suggests caveolin-1 as a therapeutic target to protect the blood-brain barrier (BBB) during stroke treatment.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Thrombolysis with tissue plasminogen activator (tPA) is crucial for ischemic stroke treatment.
  • tPA increases matrix metalloproteinase-9 (MMP-9) activity, exacerbating blood-brain barrier (BBB) injury and hemorrhage risk.
  • The precise mechanism of tPA-induced MMP-9 elevation remains unclear.

Purpose of the Study:

  • To investigate the role of caveolin-1 in mediating tPA-induced MMP-9 synthesis and activity.
  • To elucidate the molecular mechanisms linking tPA, caveolin-1, and MMP-9 in endothelial cells.

Main Methods:

  • Brain microvascular endothelial cells (bEnd3) were treated with varying doses of tPA.
  • MMP-9 levels in conditioned media and cell extracts were analyzed using gelatin zymography.
  • Caveolin-1 (Cav-1) protein and MMP-9 mRNA levels were assessed after tPA treatment and Cav-1 knockdown via siRNA.

Main Results:

  • tPA (20 μg/mL) significantly increased extracellular MMP-9 while decreasing intracellular levels.
  • tPA treatment elevated caveolin-1 protein levels by 2.3-fold in endothelial cells.
  • Knockdown of Cav-1 inhibited tPA-induced MMP-9 mRNA up-regulation and extracellular secretion.

Conclusions:

  • Caveolin-1 plays a critical role in mediating tPA-induced MMP-9 up-regulation in endothelial cells.
  • Caveolin-1 appears to facilitate MMP-9 synthesis and extracellular release, but not necessarily secretion.
  • Targeting caveolin-1 may offer a novel therapeutic strategy to protect the BBB during thrombolytic therapy for stroke.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.8K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K